AURA vs CE · $406.7M cap vs rev $10.28B
Aura Biosciences Inc (AURA) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Aura Biosciences Inc (AURA) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
AURA does not have a complete income-statement cache yet.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
AURA currently screens at market cap $406.7M. CE currently screens at market cap $5.92B.
Not investment advice. Open the AURA and CE stock pages for the full models.
Not investment advice.